Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 25,218Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4GENENTECH INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Dosage Form : TABLET;ORAL

Dosage Strength : 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2018-10-24

Application Number : 210854

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Dosage Form : TABLET;ORAL

Dosage Strength : 40MG

Approval Date : 2018-10-24

Application Number : 210854

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Dosage Form : TABLET;ORAL

Dosage Strength : 80MG

Approval Date : 2021-03-18

Application Number : 210854

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 2MG/ML

Approval Date : 2020-11-23

Application Number : 214410

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank